Company
Last deal
$30.7M
Local Amount - CNY 200.M
Amount
Series A
Stage
27.07.2021
Date
1
all rounds
$30.7M
Total amount
General
About Company
Dinfectome develops molecular detection tech for pathogenic microorganisms, improving liquid biopsy and precision medicine in cancer.
Industry
Sector :
Subsector :
Also Known As
迪飞医学
founded date
01.01.2018
Last funding type
Series A
IPO status
Private